A model of the mitochondrial basis of bipolar disorder

Neuroscience and Biobehavioral Reviews

Volumn 74, Issue , 2017, Pages 1-20

  Morris, Gerwyn ^a   Walder, Ken ^b   McGee, Sean L ^b   Dean, Olivia M ^b   Tye, Susannah J ^b,c,d,e   Maes, Michael ^b   Berk, Michael ^b,f  

^a Tir Na Nog   (United Kingdom)

^b DEAKIN UNIVERSITY   (Australia)

^c MAYO CLINIC   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

AMPK; Bcl 2; BDNF; Bipolar disorder; Depression; GSK 3; Inflammation; Mania; Melatonin; Mitochondria; Oxidative stress; p53; SIRT 1

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM ION; CYTOKINE; DOPAMINE; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELATONIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NITRIC OXIDE; PER1 PROTEIN; PER2 PROTEIN; PER3 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; SIRTUIN 3; TIM PROTEIN; TRANSCRIPTION FACTOR ARNTL; TRANSCRIPTION FACTOR CLOCK; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIC ACID;

AKT GENE; AMPK GENE; APOPTOSIS; ARNTL1 GENE; BDNF GENE; BIPOLAR DISORDER; BMAL1 GENE; CALCIUM CELL LEVEL; CELL DAMAGE; CELL DEATH; CELL FUNCTION; CLOCK GENE; CRY1 GENE; CRY2 GENE; CYTOTOXICITY; ENZYME MECHANISM; HUMAN; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NAD GENE; NEUROTOXICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; P13K GENE; PER1 GENE; PER2 GENE; PER3 GENE; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; SIRT1 GENE; SIRT3 GENE; TIM GENE; TUMOR SUPPRESSOR GENE; UPREGULATION; MOOD DISORDER;

BIPOLAR DISORDER; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MITOCHONDRIA; MOOD DISORDERS; PHOSPHATIDYLINOSITOL 3-KINASES;

EID: 85009366164     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2017.01.014     Document Type: Review

References (410)

1. Öngür, D., Jensen, J.E., Prescot, A.P., Stork, C., Lundy, M., Cohen, B.M., Renshaw, P.F., Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol. Psychiatry 64 (2008), 718–726.
2. Abe, N., Uchida, S., Otsuki, K., Hobara, T., Higuchi, F., Watanabe, Y., Altered gene expression of sirtuins in mood disorder patients. Neurosci. Res., 68, 2010, e318.
3. Abedelmalek, S., Souissi, N., Chtourou, H., Denguezli, M., Aouichaoui, C., Ajina, M., Aloui, A., Dogui, M., Haddouk, S., Tabka, Z., Effects of partial sleep deprivation on proinflammatory cytokines, growth hormone, and steroid hormone concentrations during repeated brief sprint interval exercise. Chronobiol. Int. 30 (2013), 502–509.
4. Acin-Perez, R., Bayona-Bafaluy, M., Fernandez-Silva, P., Moreno-Loshuertos, R., Perez-Martos, A., Bruno, C., Respiratory complex III is required to maintain complex I in mammalian mitochondria. Mol. Cell 13 (2004), 805–815.
5. Acin-Perez, R., Salazar, E., Kamenetsky, M., Buck, J., Levin, L.R., Manfredi, G., Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. Cell Metab. 9 (2009), 265–276.
6. Acuna Castroviejo, D., Lopez, L.C., Escames, G., Lopez, A., Garcia, J.A., Reiter, R.J., Melatonin-mitochondria interplay in health and disease. Curr. Top. Med. Chem. 11 (2011), 221–240.
7. Afanador, L., Keeling, D., Campbell, K., Campbell, K., Roltsch, E., Zimmer, D., Aberrant calcium signaling modulates inflammatory and PI3/Akt pathways in Alzheimer's disease. Alzheimer Dement., 9, 2013, P352.
8. Ahuja, M., Jha, A., Maleth, J., Park, S., Muallem, S., cAMP and Ca(2)(+) signaling in secretory epithelia: crosstalk and synergism. Cell Calcium 55 (2014), 385–393.
9. Akl, H., Vervloessem, T., Kiviluoto, S., Bittremieux, M., Parys, J.B., De Smedt, H., Bultynck, G., A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum. Biochim. Biophys. Acta (BBA)—Mol. Cell Res. 1843 (2014), 2240–2252.
10. Albert, U., De Cori, D., Aguglia, A., Barbaro, F., Bogetto, F., Maina, G., Increased uric acid levels in bipolar disorder subjects during different phases of illness. J. Affect. Disord. 173 (2015), 170–175.
11. Alexander, J.J., Anderson, A.J., Barnum, S.R., Stevens, B., Tenner, A.J., The complement cascade: Yin-Yang in neuroinflammation-neuro-protection and -degeneration. J. Neurochem. 107 (2008), 1169–1187.
12. Allen, P.J., Creatine metabolism and psychiatric disorders: does creatine supplementation have therapeutic value?. Neurosci. Biobehav. Rev. 36 (2012), 1442–1462.
13. Amigo, I., Traba, J., Gonzalez-Barroso, M.M., Rueda, C.B., Fernandez, M., Rial, E., Sanchez, A., Satrustegui, J., del Arco, A., Glucagon regulation of oxidative phosphorylation requires an increase in matrix adenine nucleotide content through Ca2+ activation of the mitochondrial ATP-Mg/Pi carrier SCaMC-3. J. Biol. Chem. 288 (2013), 7791–7802.
14. Anand, A., Barkay, G., Dzemidzic, M., Albrecht, D., Karne, H., Zheng, Q.H., Hutchins, G.D., Normandin, M.D., Yoder, K.K., Striatal dopamine transporter availability in unmedicated bipolar disorder. Bipolar Disord. 13 (2011), 406–413.
15. Anderson, R.F., Harris, T.A., Dopamine and uric acid act as antioxidants in the repair of DNA radicals: implications in Parkinson's disease. Free Radic. Res. 37 (2003), 1131–1136.
16. Anderson, K.A., Hirschey, M.D., Mitochondrial protein acetylation regulates metabolism. Essays Biochem. 52 (2012), 23–35.
17. Andreazza, A.C., Young, L.T., The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment. Int. J. Neuropsychopharmacol. 17 (2013), 1039–1052.
18. Andreazza, A.C., Andersen, M.L., Alvarenga, T.A., de-Oliveira, M.R., Armani, F., Ruiz, F.S., Giglio, L., Moreira, J.C.F., Kapczinski, F., Tufik, S., Impairment of the mitochondrial electron transport chain due to sleep deprivation in mice. J. Psychiatr. Res. 44 (2010), 775–780.
19. Andreazza, A.C., Shao, L., Wang, J.F., Young, L.T., Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch. Gen. Psychiatry 67 (2010), 360–368.
20. Antoch, M.P., Kondratov, R.V., Takahashi, J.S., Circadian clock genes as modulators of sensitivity to genotoxic stress. Cell Cycle (Georgetown, Tex.) 4 (2005), 901–907.
21. Aprille, J.R., Rohweder-Dunn, G., Brennan, W.A., Kelley, R.T., Nosek, M.T., Mitochondrial function after acute alteration of the endogenous insulin-to-glucagon ratio. Biochem. Biophys. Res. Commun. 142 (1987), 315–321.
22. Arnold, D., Bore, P., Radda, G., Styles, P., Taylor, D., Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome. Lancet 1 (1984), 1367–1369.
23. Aschbacher, K., O'Donovan, A., Wolkowitz, O.M., Dhabhar, F.S., Su, Y., Epel, E., Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity. Psychoneuroendocrinology 38 (2013), 1698–1708.
24. Asher, G., Gatfield, D., Stratmann, M., Reinke, H., Dibner, C., Kreppel, F., Mostoslavsky, R., Alt, F.W., Schibler, U., SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 134 (2008), 317–328.
25. Atkinson, S.E., Maywood, E.S., Chesham, J.E., Wozny, C., Colwell, C.S., Hastings, M.H., Williams, S.R., Cyclic AMP signaling control of action potential firing rate and molecular circadian pacemaking in the suprachiasmatic nucleus. J. Biol. Rhythms 26 (2011), 210–220.
26. Auciello, F.R., Ross, F.A., Ikematsu, N., Hardie, D.G., Oxidative stress activates AMPK in cultured cells primarily by increasing cellular AMP and/or ADP. FEBS Lett. 588 (2014), 3361–3366.
27. Bai, P., Canto, C., Oudart, H., Brunyanszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R.H., Schoonjans, K., Schreiber, V., Sauve, A.A., Menissier-de Murcia, J., Auwerx, J., PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13 (2011), 461–468.
28. Bai, Y.-M., Su, T.-P., Li, C.-T., Tsai, S.-J., Chen, M.-H., Tu, P.-C., Chiou, W.-F., Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls. Bipolar Disord. 17 (2014), 269–277.
29. Bai, Y.M., Su, T.P., Tsai, S.J., Wen-Fei, C., Li, C.T., Pei-Chi, T., Mu-Hong, C., Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder. J. Affect. Disord. 166 (2014), 187–192.
30. Baines, C.P., Song, C.X., Zheng, Y.T., Wang, G.W., Zhang, J., Wang, O.L., Guo, Y., Bolli, R., Cardwell, E.M., Ping, P., Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ. Res. 92 (2003), 873–880.
31. Bakkar, N., Wang, J., Ladner, K.J., Wang, H., Dahlman, J.M., Carathers, M., Acharyya, S., Rudnicki, M.A., Hollenbach, A.D., Guttridge, D.C., IKK/NF-κB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J. Cell Biol. 180 (2008), 787–802.
32. Bakkar, N., Ladner, K., Canan, B.D., Liyanarachchi, S., Bal, N.C., Pant, M., Periasamy, M., Li, Q., Janssen, P.M.L., Guttridge, D.C., IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. J. Cell Biol. 196 (2012), 497–511.
33. Bakshi, R., Shaikh, Z., Miletich, R., Czarnecki, D., Dmochowski, J., Henschel, K., Janardhan, V., Dubey, N., Kinkel, P., Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult. Scler. 6 (2000), 181–185.
34. Balaban, R., Cardiac energy metabolism homeostasis: role of cytosolic calcium. J. Mol. Cell. Cardiol. 34 (2002), 1259–1271.
35. Balaban, R.S., The role of Ca2+ signaling in the coordination of mitochondrial ATP production with cardiac work. Biochim. Biophys. Acta (BBA)—Bioenergetics 1787 (2009), 1334–1341.
36. Baniene, R., Nauciene, Z., Maslauskaite, S., Baliutyte, G., Mildazienė, V., Contribution of ATP synthase to stimulation of respiration by Ca2+ in heart mitochondria. IEE Proc. Syst. Biol., 153, 2006, 350.
37. Barbosa, I.G., Bauer, M.E., Machado-Vieira, R., Teixeira, A.L., Cytokines in bipolar disorder: paving the way for neuroprogression. Neural Plas. 2014 (2014), 1–9.
38. Barbosa, D.J., Capela, J.P., Feio-Azevedo, R., Teixeira-Gomes, A., Bastos Mde, L., Carvalho, F., Mitochondria: key players in the neurotoxic effects of amphetamines. Arch. Toxicol. 89 (2015), 1695–1725.
39. Baughman, J.M., Perocchi, F., Girgis, H.S., Plovanich, M., Belcher-Timme, C.A., Sancak, Y., Bao, X.R., Strittmatter, L., Goldberger, O., Bogorad, R.L., Koteliansky, V., Mootha, V.K., Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476 (2011), 341–345.
40. Baxter, L., Phelps, M., Mazziotta, J., Schwartz, J., Gerner, R., Selin, C., Cerebral metabolic rates for glucose in mood disorders: studies with positron emission tomography and fluorodeoxyglucose F 18. Arch. Gen. Psychiatry 42 (1985), 441–447.
41. Baxter, L.R., Cerebral metabolic rates for glucose in mood disorders. Arch. Gen. Psychiatry, 42, 1985, 441.
42. Baxter, L.R., Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch. Gen. Psychiatry, 46, 1989, 243.
43. Beaulieu, J.-M., Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors. Front. Mol. Neurosci., 4, 2011.
44. Becking, K., Boschloo, L., Vogelzangs, N., Haarman, B.C.M., Riemersma-van der Lek, R., Penninx, B.W.J.H., Schoevers, R.A., The association between immune activation and manic symptoms in patients with a depressive disorder. Transl. Psychiatry, 3, 2013, e314.
45. Beech, R.D., Lowthert, L., Leffert, J.J., Mason, P.N., Taylor, M.M., Umlauf, S., Lin, A., Lee, J.Y., Maloney, K., Muralidharan, A., Lorberg, B., Zhao, H., Newton, S.S., Mane, S., Epperson, C.N., Sinha, R., Blumberg, H., Bhagwagar, Z., Increased peripheral blood expression of electron transport chain genes in bipolar depression. Bipolar Disord. 12 (2010), 813–824.
46. Bei, E.S., Salpeas, V., Alevizos, B., Anagnostara, C., Pappa, D., Moutsatsou, P., Pattern of heat shock factor and heat shock protein expression in lymphocytes of bipolar patients: increased HSP70-glucocorticoid receptor heterocomplex. J. Psychiatr. Res. 47 (2013), 1725–1736.
47. Bellet, M.M., Sassone-Corsi, P., Mammalian circadian clock and metabolism—the epigenetic link. J. Cell Sci. 123 (2010), 3837–3848.
48. Ben-Shachar, D., Karry, R., Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2. PLoS One., 2, 2007, e817.
49. Ben-Shachar, D., Karry, R., Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS One, 3, 2008, e3676.
50. Ben-Shachar, D., Zuk, R., Gazawi, H., Ljubuncic, P., Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders. Biochem. Pharmacol. 67 (2004), 1965–1974.
51. Bender, E., Kadenbach, B., The allosteric ATP-inhibition of cytochrome c oxidase activity is reversibly switched on by cAMP-dependent phosphorylation. FEBS Lett. 466 (2000), 130–134.
52. Benes, F.M., Matzilevich, D., Burke, R.E., Walsh, J., The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol. Psychiatry 11 (2005), 241–251.
53. Berk, M., Bodemer, W., Van Oudenhove, T., Butkow, N., The platelet intracellular calcium response to serotonin is augmented in bipolar manic and depressed patients. Hum. Psychopharmacol.: Clin. Exp. 10 (1995), 189–193.
54. Berk, M., Dodd, S., Kauer-Sant?Anna, M., Malhi, G.S., Bourin, M., Kapczinski, F., Norman, T., Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr. Scand. 116 (2007), 41–49.
55. Berk, M., Kapczinski, F., Andreazza, A., Dean, O., Giorlando, F., Maes, M., Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 35 (2011), 804–817.
56. Bertolino, A., Frye, M., Callicott, J.H., Mattay, V.S., Rakow, R., Shelton-Repella, J., Post, R., Weinberger, D.R., Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol. Psychiatry 53 (2003), 906–913.
57. Beurel, E., Grieco, S.F., Jope, R.S., Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases. Pharmacol. Ther. 148 (2015), 114–131.
58. Bielekova, B., Richert, N., Herman, M.L., Ohayon, J., Waldmann, T.A., McFarland, H., Martin, R., Blevins, G., Intrathecal effects of daclizumab treatment of multiple sclerosis. Neurology 77 (2011), 1877–1886.
59. Boerries, M., Most, P., Gledhill, J.R., Walker, J.E., Katus, H.A., Koch, W.J., Aebi, U., Schoenenberger, C.A., Ca2+-dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytes. Mol. Cell. Biol. 27 (2007), 4365–4373.
60. Bonneau, B., Prudent, J., Popgeorgiev, N., Gillet, G., Non-apoptotic roles of Bcl-2 family: the calcium connection. Biochim. Biophys. Acta (BBA)—Mol. Cell Res. 1833 (2013), 1755–1765.
61. Bortell, N., Najera, J.A., Sanchez-Alavez, M., Marcondes, M.C.G., In vivo effects of methamphetamine on brown fat reactive oxygen species and mitochondria. Temp.: Multidiscip. Biomed. J., 2, 2015, 453.
62. Bortolasci, C.C., Vargas, H.O., Vargas Nunes, S.O., de Melo, L.G.P., de Castro, M.R.P., Moreira, E.G., Dodd, S., Barbosa, D.S., Berk, M., Maes, M., Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder. J. Affect. Disord. 179 (2015), 148–155.
63. Brady, R.O. Jr., Cooper, A., Jensen, J.E., Tandon, N., Cohen, B., Renshaw, P., Keshavan, M., Ongur, D., A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder. Transl. Psychiatry, 2, 2012, e160.
64. Brandauer, J., Vienberg, S.G., Andersen, M.A., Ringholm, S., Risis, S., Larsen, P.S., Kristensen, J.M., Frosig, C., Leick, L., Fentz, J., Jorgensen, S., Kiens, B., Wojtaszewski, J.F., Richter, E.A., Zierath, J.R., Goodyear, L.J., Pilegaard, H., Treebak, J.T., AMP-activated protein kinase regulates nicotinamide phosphoribosyl transferase expression in skeletal muscle. J. Physiol. 591 (2013), 5207–5220.
65. Brennan, J.P., Bardswell, S.C., Burgoyne, J.R., Fuller, W., Schröder, E., Wait, R., Begum, S., Kentish, J.C., Eaton, P., Oxidant-induced activation of type I protein kinase a is mediated by RI subunit interprotein disulfide bond formation. J. Biol. Chem. 281 (2006), 21827–21836.
66. Brietzke, E., Stertz, L., Fernandes, B.S., Kauer-Sant'Anna, M., Mascarenhas, M., Escosteguy Vargas, A., Chies, J.A., Kapczinski, F., Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J. Affect. Disord. 116 (2009), 214–217.
67. Brookes, P.S., Yoon, Y., Robotham, J.L., Anders, M.W., Sheu, S.-S., Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol.—Cell Physiol. 287 (2004), C817–C833.
68. Caliyurt, O., Altiay, G., Resting energy expenditure in manic episode. Bipolar Disord. 11 (2009), 102–106.
69. Callaly, E., Walder, K., Morris, G., Maes, M., Debnath, M., Berk, M., Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy. Mini Rev. Med. Chem. 15 (2015), 355–365.
70. Cantó, C., Gerhart-Hines, Z., Feige, J.N., Lagouge, M., Noriega, L., Milne, J.C., Elliott, P.J., Puigserver, P., Auwerx, J., AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458 (2009), 1056–1060.
71. Cantó, C., Jiang, L.Q., Deshmukh, A.S., Mataki, C., Coste, A., Lagouge, M., Zierath, J.R., Auwerx, J., Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 11 (2010), 213–219.
72. Cantó, C., Houtkooper Riekelt, H., Pirinen, E., Youn Dou, Y., Oosterveer Maaike, H., Cen, Y., Fernandez-Marcos Pablo, J., Yamamoto, H., Andreux Pénélope, A., Cettour-Rose, P., Gademann, K., Rinsch, C., Schoonjans, K., Sauve Anthony, A., Auwerx, J., The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 15 (2012), 838–847.
73. Cantó, C., Menzies Keir, J., Auwerx, J., NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 22 (2015), 31–53.
74. Canto, C., Gerhart-Hines, Z., Feige, J.N., Lagouge, M., Noriega, L., Milne, J.C., Elliott, P.J., Puigserver, P., Auwerx, J., AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458 (2009), 1056–1060.
75. Canto, C., Menzies, K.J., Auwerx, J., NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 22 (2015), 31–53.
76. Cataldo, A., McPhie, D., Lange, N., Punzell, S., Elmiligy, S., Ye, N., Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am. J. Pathol. 177 (2010), 575–585.
77. Cataldo, A.M., McPhie, D.L., Lange, N.T., Punzell, S., Elmiligy, S., Ye, N.Z., Froimowitz, M.P., Hassinger, L.C., Menesale, E.B., Sargent, L.W., Logan, D.J., Carpenter, A.E., Cohen, B.M., Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am. J. Pathol. 177 (2010), 575–585.
78. Cecil, K.M., DelBello, M.P., Morey, R., Strakowski, S.M., Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord. 4 (2002), 357–365.
79. Chance, B., Williams, G.R., Respiratory enzymes in oxidative phosphorylation: I. Kinetics of oxygen utilization. J. Biol. Chem. 217 (1955), 383–393.
80. Chang, A., Li, P.P., Warsh, J.J., Altered cAMP-dependent protein kinase subunit immunolabeling in post-mortem brain from patients with bipolar affective disorder. J. Neurochem. 84 (2003), 781–791.
81. Chang, A., Li, P.P., Warsh, J.J., cAMP-Dependent protein kinase (PKA) subunit mRNA levels in postmortem brain from patients with bipolar affective disorder (BD). Brain Res. Mol. Brain Res. 116 (2003), 27–37.
82. Chang, K., Adleman, N., Dienes, K., Barnea-Goraly, N., Reiss, A., Ketter, T., Decreased N-acetylaspartate in children with familial bipolar disorder. Biol. Psychiatry 53 (2003), 1059–1065.
83. Chang, A.H.K., Sancheti, H., Garcia, J., Kaplowitz, N., Cadenas, E., Han, D., Respiratory substrates regulate S-nitrosylation of mitochondrial proteins through a thiol-dependent pathway. Chem. Res. Toxicol. 27 (2014), 794–804.
84. Chen, Z.X., Pervaiz, S., Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells. Cell Death Differ. 14 (2007), 1617–1627.
85. Chen, R., Valencia, I., Zhong, F., McColl, K.S., Roderick, H.L., Bootman, M.D., Berridge, M.J., Conway, S.J., Holmes, A.B., Mignery, G.A., Velez, P., Distelhorst, C.W., Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. J. Cell Biol. 166 (2004), 193–203.
86. Chen, S., Owens, G.C., Edelman, D.B., Dopamine inhibits mitochondrial motility in hippocampal neurons. PLoS One, 3, 2008, e2804.
87. Chen, J., Fang, Y., Kemp, D.E., Calabrese, J.R., Gao, K., Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms. Curr. Psychiatry Rep. 12 (2010), 512–521.
88. Chen, X.-H., Zhao, Y.-P., Xue, M., Ji, C.-B., Gao, C.-L., Zhu, J.-G., Qin, D.-N., Kou, C.-Z., Qin, X.-H., Tong, M.-L., Guo, X.-R., TNF-α induces mitochondrial dysfunction in 3T3-L1 adipocytes. Mol. Cell. Endocrinol. 328 (2010), 63–69.
89. Chen, W.-T., Huang, T.-L., Tsai, M.-C., Bcl-2 associated with severity of manic symptoms in bipolar patients in a manic phase. Psychiatry Res. 225 (2015), 305–308.
90. Cherry, A.D., Piantadosi, C.A., Regulation of mitochondrial biogenesis and its intersection with inflammatory responses. Antioxid. Redox Signal. 22 (2015), 965–976.
91. Chiara, F., Gambalunga, A., Sciacovelli, M., Nicolli, A., Ronconi, L., Fregona, D., Bernardi, P., Rasola, A., Trevisan, A., Chemotherapeutic induction of mitochondrial oxidative stress activates GSK-3alpha/beta and Bax, leading to permeability transition pore opening and tumor cell death. Cell Death Dis., 3, 2012, e444.
92. Choi, H.J., Kang, K.S., Fukui, M., Zhu, B.T., Critical role of the JNK-p53-GADD45α apoptotic cascade in mediating oxidative cytotoxicity in hippocampal neurons. Br. J. Pharmacol. 162 (2010), 175–192.
93. Chu, W.J., Delbello, M.P., Jarvis, K.B., Norris, M.M., Kim, M.J., Weber, W., Lee, J.H., Strakowski, S.M., Adler, C.M., Magnetic resonance spectroscopy imaging of lactate in patients with bipolar disorder. Psychiatry Res. 213 (2013), 230–234.
94. Chung, S.C.M., Ha, T.S., Yang, J.C., Park, T.W., Chung, Y.C., Jung, A.J., Creatine kinase level may not be associated with motor activity but with simple mood state in Korean unmedicated bipolar patients. Eur. Neuropsychopharmacol. 19 (2009), S465–S466.
95. Chung, C.P., Schmidt, D., Stein, C.M., Morrow, J.D., Salomon, R.M., Increased oxidative stress in patients with depression and its relationship to treatment. Psychiatry Res. 206 (2013), 213–216.
96. Cicerchi, C., Li, N., Kratzer, J., Garcia, G., Roncal-Jimenez, C.A., Tanabe, K., Hunter, B., Rivard, C.J., Sautin, Y.Y., Gaucher, E.A., Johnson, R.J., Lanaspa, M.A., Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids. FASEB J. 28 (2014), 3339–3350.
97. Clay, H., Sillivan, S., Konradi, C., Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int. J. Dev. Neurosci. 29 (2011), 311–324.
98. Cunha, M.P., Martín-de-Saavedra, M.D., Romero, A., Egea, J., Ludka, F.K., Tasca, C.I., Farina, M., Rodrigues, A.L.S., López, M.G., Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an In vitro Parkinson's model. ASN Neurol., 6, 2014.
99. Czerniczyniec, A., Bustamante, J., Lores-Arnaiz, S., Dopamine enhances mtNOS activity: implications in mitochondrial function. Biochim. Biophys. Acta (BBA)—Bioenergetics 1767 (2007), 1118–1125.
100. Dager, S.R., Friedman, S.D., Parow, A., Demopulos, C., Stoll, A.L., Lyoo, I.K., Dunner, D.L., Renshaw, P.F., Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry 61 (2004), 450–458.
101. Das, A.M., Regulation of mitochondrial ATP synthase activity in human myocardium. Clin. Sci. 94 (1998), 499–504.
102. De Berardis, D., Conti, C.M., Campanella, D., Carano, A., Di Giuseppe, B., Valchera, A., Tancredi, L., Serroni, N., Pizzorno, A.M., Fulcheri, M., Gambi, F., Sepede, G., Moschetta, F.S., Salerno, R.M., Ferro, F.M., Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder. J. Biol. Regul. Homeost. Agents 22 (2008), 195–200.
103. De Marchi, U., Thevenet, J., Hermant, A., Dioum, E., Wiederkehr, A., Calcium co-regulates oxidative metabolism and ATP synthase-dependent respiration in pancreatic beta cells. J. Biol. Chem. 289 (2014), 9182–9194.
104. De Rasmo, D., Signorile, A., Roca, E., Papa, S., cAMP response element-binding protein (CREB) is imported into mitochondria and promotes protein synthesis. FEBS J. 276 (2009), 4325–4333.
105. De Simone, V., Franze, E., Ronchetti, G., Colantoni, A., Fantini, M.C., Di Fusco, D., Sica, G.S., Sileri, P., MacDonald, T.T., Pallone, F., Monteleone, G., Stolfi, C., Th17-type cytokines, IL-6 and TNF-[alpha] synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene 34 (2015), 3493–3503.
106. De Stefani, D., Raffaello, A., Teardo, E., Szabò, I., Rizzuto, R., A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476 (2011), 336–340.
107. Dean, O.M., Turner, A., Malhi, G.S., Ng, C., Cotton, S.M., Dodd, S., Sarris, J., Samuni, Y., Tanious, M., Dowling, N., Waterdrinker, A., Smith, D., Berk, M., Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression. Rev. Bras. Psiquiatria (Sao Paulo, Brazil: 1999) 37 (2015), 3–12.
108. Deicken, R.F., Pegues, M.P., Anzalone, S., Feiwell, R., Soher, B., Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am. J. Psychiatry 160 (2003), 873–882.
109. Dienes, K.A., Hammen, C., Henry, R.M., Cohen, A.N., Daley, S.E., The stress sensitization hypothesis: understanding the course of bipolar disorder. J. Affect. Disord. 95 (2006), 43–49.
110. Dinkova-Kostova, A.T., Abramov, A.Y., The emerging role of Nrf2 in mitochondrial function. Free Radic. Biol. Med. 88:Part B (2015), 179–188.
111. Dolle, C., Rack, J.G., Ziegler, M., NAD and ADP-ribose metabolism in mitochondria. FEBS J. 280 (2013), 3530–3541.
112. Dorofeeva, N.A., Nikitina, L.S., Glazova, M.V., Kirillova, O.D., Chernigovskaya, E.V., p53 Inactivation leads to enhancement of tyrosine hydroxylase biosynthesis in brain dopaminergic neurons. J. Evol. Biochem. Phys. 49 (2013), 175–182.
113. Douglas, D.N., Pu, C.H., Lewis, J.T., Bhat, R., Anwar-Mohamed, A., Logan, M., Lund, G., Addison, W.R., Lehner, R., Kneteman, N.M., Oxidative stress attenuates lipid synthesis and increases mitochondrial fatty acid oxidation in hepatoma cells infected with hepatitis C virus. J. Biol. Chem. 291 (2016), 1974–1990.
114. Drevets, W., Price, J., Simpson, J., Todd, R., Reich, T., Vannier, M., Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 (1997), 824–827.
115. Dubovsky, S.L., Lee, C., Christiano, J., Murphy, J., Elevated platelet intracellular calcium concentration in bipolar depression. Biol. Psychiatry 29 (1991), 441–450.
116. Dubovsky, S.L., Daurignac, E., Leonard, K.E., Increased platelet intracellular calcium ion concentration is specific to bipolar disorder. J. Affect. Disord. 164 (2014), 38–42.
117. Elhaik, E., Zandi, P., Dysregulation of the NF-kappaB pathway as a potential inducer of bipolar disorder. J. Psychiatr. Res. 70 (2015), 18–27.
118. Fan, Y., Mao, R., Yang, J., NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell 4 (2013), 176–185.
119. Feng, Y., Xia, Y., Yu, G., Shu, X., Ge, H., Zeng, K., Wang, J., Wang, X., Cleavage of GSK-3beta by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK-3beta activity induced by H(2)O(2). J. Neurochem. 126 (2013), 234–242.
120. Fernandes, B.S., Molendijk, M.L., Köhler, C.A., Soares, J.C., Leite, C.M.G.S., Machado-Vieira, R., Ribeiro, T.L., Silva, J.C., Sales, P.M.G., Quevedo, J., Oertel-Knöchel, V., Vieta, E., González-Pinto, A., Berk, M., Carvalho, A.F., Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies. BMC Med., 13, 2015, 289.
121. Fiermonte, G., De Leonardis, F., Todisco, S., Palmieri, L., Lasorsa, F.M., Palmieri, F., Identification of the Mitochondrial ATP-Mg/Pi Transporter: bacterial expression, reconstitution, functional, characterization, and tissue distribution. J. Biol. Chem. 279 (2004), 30722–30730.
122. Frey, B.N., Stanley, J.A., Nery, F.G., Monkul, E.S., Nicoletti, M.A., Chen, H.H., Hatch, J.P., Caetano, S.C., Ortiz, O., Kapczinski, F., Soares, J.C., Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study. Bipolar Disord. 9:Suppl. 1 (2007), 119–127.
123. Görlach, A., Bertram, K., Hudecova, S., Krizanova, O., Calcium and ROS: a mutual interplay. Redox Biol. 6 (2015), 260–271.
124. Gabriel, J.L., Plaut, G.W.E., Inhibition of bovine heart NAD-specific isocitrate dehydrogenase by reduced pyridine nucleotides: modulation of inhibition by ADP, NAD+, calcium(2+), citrate, and isocitrate. Biochemistry 23 (1984), 2773–2778.
125. Gao, M., Wang, J., Wang, W., Liu, J., Wong, C.-W., Phosphatidylinositol 3-kinase affects mitochondrial function in part through inducing peroxisome proliferator-activated receptor γ coactivator-1β expression. Br. J. Pharmacol. 162 (2011), 1000–1008.
126. Garcia, O., Almeida, A., Massieu, L., Bolanos, J.P., Increased mitochondrial respiration maintains the mitochondrial membrane potential and promotes survival of cerebellar neurons in an endogenous model of glutamate receptor activation. J. Neurochem. 92 (2005), 183–190.
127. Gaspar, L., van de Werken, M., Johansson, A.S., Moriggi, E., Owe-Larsson, B., Kocks, J.W., Lundkvist, G.B., Gordijn, M.C., Brown, S.A., Human cellular differences in cAMP-CREB signaling correlate with light-dependent melatonin suppression and bipolar disorder. Eur. J. Neurosci. 40 (2014), 2206–2215.
128. Gellerich, F.N., Gizatullina, Z., Arandarcikaite, O., Jerzembek, D., Vielhaber, S., Seppet, E., Striggow, F., Extramitochondrial Ca2+ in the nanomolar range regulates glutamate-dependent oxidative phosphorylation on demand. PLoS One, 4, 2009, e8181.
129. Gellerich, Frank, N., Gizatullina, Z., Trumbekaite, S., Korzeniewski, B., Gaynutdinov, T., Seppet, E., Vielhaber, S., Heinze, H.-J., Striggow, F., Cytosolic Ca 2+ regulates the energization of isolated brain mitochondria by formation of pyruvate through the malate-aspartate shuttle. Biochem. J. 443 (2012), 747–755.
130. Gellerich, F.N., Gizatullina, Z., Gainutdinov, T., Muth, K., Seppet, E., Orynbayeva, Z., Vielhaber, S., The control of brain mitochondrial energization by cytosolic calcium: the mitochondrial gas pedal. IUBMB Life 65 (2013), 180–190.
131. Genc, A., Kalelioglu, T., Karamustafalioglu, N., Tasdemir, A., Gungor, F.C., Genc, E.S., Incir, S., Ilnem, C., Emul, M., Level of plasma thioredoxin in male patients with manic episode at initial and post-electroconvulsive or antipsychotic treatment. Psychiatry Clin. Neurosci. 69 (2015), 344–350.
132. Geoffroy, P., Etain, B., Sportiche, S., Bellivier, F., Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response. Int. J. Bipolar Disord., 2, 2014, 5.
133. Glancy, B., Balaban, R.S., Role of mitochondrial Ca2+ in the regulation of cellular energetics. Biochemistry 51 (2012), 2959–2973.
134. Glantzounis, G.K., Tsimoyiannis, E.C., Kappas, A.M., Galaris, D.A., Uric acid and oxidative stress. Curr. Pharm. Des. 11 (2005), 4145–4151.
135. Goldsmith, C.S., Bell-Pedersen, D., Diverse roles for MAPK signaling in circadian clocks. Adv. Genet. 84 (2013), 1–39.
136. Gonzalez, R., The relationship between bipolar disorder and biological rhythms. J. Clin. Psychiatry 75 (2014), e323–e331.
137. Goo, C.K., Lim, H.Y., Ho, Q.S., Too, H.-P., Clement, M.-V., Wong, K.P., PTEN/Akt signaling controls mitochondrial respiratory capacity through 4E-BP1. PLoS One, 7, 2012, e45806.
138. Grivennikov, S., Karin, M., Dangerous liaisons: STAT3 and NF-(B collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 21 (2010), 11–19.
139. Gruno, M., Oxidative phosphorylation and its coupling to mitochondrial creatine and adenylate kinases in human gastric mucosa. AJP: Regul. Integr. Comp. Physiol. 291 (2006), R936–R946.
140. Gu, Y., Han, B., Wang, L., Chang, Y., Zhu, L., Ren, W., Yan, M., Zhang, X., He, J., Low serum levels of uric acid are associated with development of poststroke depression. Medicine (Baltimore), 94, 2015, e1897.
141. Guha, M., Fang, J.K., Monks, R., Birnbaum, M.J., Avadhani, N.G., Activation of akt is essential for the propagation of mitochondrial respiratory stress signaling and activation of the transcriptional coactivator heterogeneous ribonucleoprotein A2. Mol. Biol. Cell 21 (2010), 3578–3589.
142. Guzun, R., Timohhina, N., Tepp, K., Monge, C., Kaambre, T., Sikk, P., Kuznetsov, A.V., Pison, C., Saks, V., Regulation of respiration controlled by mitochondrial creatine kinase in permeabilized cardiac cells in situ. Biochim. Biophys. Acta (BBA)—Bioenergetics 1787 (2009), 1089–1105.
143. Hahn, C.G., Friedman, E., Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disord. 1 (1999), 81–86.
144. Halmai, Z., Dome, P., Vereczkei, A., Abdul-Rahman, O., Szekely, A., Gonda, X., Faludi, G., Sasvari-Szekely, M., Nemoda, Z., Associations between depression severity and purinergic receptor P2RX7 gene polymorphisms. J. Affect. Disord. 150 (2013), 104–109.
145. Hamakawa, H., Murashita, J., Yamada, N., Inubushi, T., Kato, N., Kato, T., Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin. Neurosci. 58 (2004), 82–88.
146. Hansford, R.G., Zorov, D., Role of mitochondrial calcium transport in the control of substrate oxidation. Bioenergetics of the Cell: Quantitative Aspects, 1998, Springer Science+Media, 359–369.
147. Harada, H., Becknell, B., Wilm, M., Mann, M., Huang, L.J., Taylor, S.S., Scott, J.D., Korsmeyer, S.J., Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell 3 (1999), 413–422.
148. Hardie, D.G., AMP-activated protein kinase—the key sensor of cellular energy charge. J. Mol. Cell. Cardiol., 33, 2001, A146.
149. Hardie, D.G., Adenosine monophosphate-activated protein kinase: a central regulator of metabolism with roles in diabetes, cancer, and viral infection. Cold Spring Harb. Symp. Quant. Biol. 76 (2011), 155–164.
150. Hardie, D.G., AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 25 (2011), 1895–1908.
151. Hashimoto, R., Hough, C., Nakazawa, T., Yamamoto, T., Chuang, D.-M., Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J. Neurochem. 80 (2002), 589–597.
152. Hayashi, A., Kasahara, T., Kametani, M., Toyota, T., Yoshikawa, T., Kato, T., Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder. Int. J. Neuropsychopharmacol., 12, 2008, 33.
153. Hayashi, A., Le Gal, K., Sodersten, K., Vizlin-Hodzic, D., Agren, H., Funa, K., Calcium-dependent intracellular signal pathways in primary cultured adipocytes and ANK3 gene variation in patients with bipolar disorder and healthy controls. Mol. Psychiatry 20 (2015), 931–940.
154. Hernlund, E., Kutuk, O., Basaga, H., Linder, S., Panaretakis, T., Shoshan, M., Cisplatin-induced nitrosylation of p53 prevents its mitochondrial translocation. Free Rad. Biol. Med. 46 (2009), 1607–1613.
155. Hirschey, M.D., Shimazu, T., Huang, J.Y., Schwer, B., Verdin, E., SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harb. Symp. Quant. Biol. 76 (2011), 267–277.
156. Hoeflich, K.P., Luo, J., Rubie, E.A., Tsao, M.S., Jin, O., Woodgett, J.R., Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406 (2000), 86–90.
157. Hofer, A.M., Interactions between calcium and cAMP signaling. Curr. Med. Chem. 19 (2012), 5768–5773.
158. Hong, Q., Qi, K., Feng, Z., Huang, Z., Cui, S., Wang, L., Fu, B., Ding, R., Yang, J., Chen, X., Wu, D., Hyperuricemia induces endothelial dysfunction via mitochondrial Na+/Ca2+ exchanger-mediated mitochondrial calcium overload. Cell Calcium 51 (2012), 402–410.
159. Hooper, D.C., Spitsin, S., Kean, R.B., Champion, J.M., Dickson, G.M., Chaudhry, I., Koprowski, H., Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. 95 (1998), 675–680.
160. Hopper, R.K., Carroll, S., Aponte, A.M., Johnson, D.T., French, S., Shen, R.-F., Witzmann, F.A., Harris, R.A., Balaban, R.S., Mitochondrial matrix phosphoproteome: effect of extra mitochondrial calcium. Biochemistry 45 (2006), 2524–2536.
161. Hosokawa, T., Momose, T., Kasai, K., Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states. Prog. Neuropsychopharmacol. Biol. Psychiatry 33 (2009), 243–250.
162. Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A., Feng, Z., Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc. Natl. Acad. Sci. 107 (2010), 7455–7460.
163. Hubbard, M.J., McHugh, N.J., Mitochondrial ATP synthase F 1-β-subunit is a calcium-binding protein. FEBS Lett. 391 (1996), 323–329.
164. Hurtado-Alvarado, G., Pavón, L., Castillo-García, S.A., Hernández, M.E., Domínguez-Salazar, E., Velázquez-Moctezuma, J., Gómez-González, B., Sleep loss as a factor to induce cellular and molecular inflammatory variations. Clin. Dev. Immunol. 2013 (2013), 1–14.
165. Huttemann, M., Lee, I., Grossman, L.I., Doan, J.W., Sanderson, T.H., Phosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: respiration, apoptosis, and human disease. Adv. Exp. Med. Biol. 748 (2012), 237–264.
166. Hwang, J.W., Yao, H., Caito, S., Sundar, I.K., Rahman, I., Redox regulation of SIRT1 in inflammation and cellular senescence. Free Rad. Biol. Med. 61 (2013), 95–110.
167. Ikeda, M., Calcium dynamics and circadian rhythms in suprachiasmatic nucleus neurons. Neuroscientist 10 (2004), 315–324.
168. Imahashi, K., Transgenic expression of bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ. Res. 95 (2004), 734–741.
169. Iwamoto, K., Bundo, M., Kato, T., Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 14 (2005), 241–253.
170. Jagannath, A., Foster, R.G., CREB signalling in bipolar disease (Commentary on Gaspar et al.). Eur. J. Neurosci., 40, 2014, 2205.
171. Jahangard, L., Soroush, S., Haghighi, M., Ghaleiha, A., Bajoghli, H., Holsboer-Trachsler, E., Brand, S., In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in-patients suffering from bipolar disorder. Eur. Neuropsychopharmacol. 24 (2014), 1210–1221.
172. Jensen, J.E., Daniels, M., Haws, C., Bolo, N.R., Lyoo, I.K., Yoon, S.J., Cohen, B.M., Stoll, A.L., Rusche, J.R., Renshaw, P.F., Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients. Exp. Clin. Psychopharmacol. 16 (2008), 199–206.
173. Johnson, S.L., Roberts, J.E., Life events and bipolar disorder: implications from biological theories. Psychol. Bull. 117 (1995), 434–449.
174. Jope, R., Roh, M.-S., Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr. Drug Targets 7 (2006), 1421–1434.
175. Kadenbach, B., Ramzan, R., Vogt, S., Degenerative diseases, oxidative stress and cytochrome c oxidase function. Trends Mol. Med. 15 (2009), 139–147.
176. Kadenbach, B., Ramzan, R., Staniek, K., Vogt, S., Mitochondrial respiration and membrane potential are regulated by the allosteric ATP-inhibition of cytochrome c oxidase. Biochim. Biophy. Acta (BBA)—Bioenergetics, 1797, 2010, 92.
177. Kagoya, Y., Yoshimi, A., Kataoka, K., Nakagawa, M., Kumano, K., Arai, S., Kobayashi, H., Saito, T., Iwakura, Y., Kurokawa, M., Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity. J. Clin. Invest. 124 (2014), 528–542.
178. Kajita, K., Mune, T., Kanoh, Y., Natsume, Y., Ishizawa, M., Kawai, Y., Yasuda, K., Sugiyama, C., Ishizuka, T., TNFα reduces the expression of peroxisome proliferator-activated receptor γ(PPARγ) via the production of ceramide and activation of atypical PKC. Diabetes Res. Clin. Pract. 66 (2004), S79–S83.
179. Kapczinski, F., Frey, B.N., Andreazza, A.C., Kauer-Sant'Anna, M., Cunha, A.B., Post, R.M., Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Rev. Bras. Psiquiatria (Sao Paulo, Brazil: 1999) 30 (2008), 243–245.
180. Karin, M., Lin, A., NF-kappaB at the crossroads of life and death. Nat. Immunol. 3 (2002), 221–227.
181. Kato, T., Takahashi, S., Shioiri, T., Inubushi, T., Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. J. Affect. Disord. 27 (1993), 53–59.
182. Kato, T., Takahashi, S., Shioiri, T., Murashita, J., Hamakawa, H., Inubushi, T., Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J. Affect. Disord. 31 (1994), 125–133.
183. Kato, J., Engel, N., Abbas, W., Herbein, G., Mahlknecht, U., Transcription factor NFκB regulates the expression of the histone deacetylase SIRT1. Clin Epigenetics, 5, 2013, 11.
184. Kauppinen, A., Suuronen, T., Ojala, J., Kaarniranta, K., Salminen, A., Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell. Signal. 25 (2013), 1939–1948.
185. Kean, R.B., Spitsin, S.V., Mikheeva, T., Scott, G.S., Hooper, D.C., 2000 The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity. J. Immunol. (Baltimore, Md.: 1950) 165 (2000), 6511–6518.
186. Kelleher, Z.T., Matsumoto, A., Stamler, J.S., Marshall, H.E., NOS2 regulation of NF-kappaB by S-nitrosylation of p65. J. Biol. Chem. 282 (2007), 30667–30672.
187. Kelly, M., Gauthier, M.S., Saha, A.K., Ruderman, N.B., Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization. Diabetes 58 (2009), 1953–1960.
188. Kesebir, S., Tatlıdil Yaylacı, E., Süner, Ö., Gültekin, B.K., Uric acid levels may be a biological marker for the differentiation of unipolar and bipolar disorder: the role of affective temperament. J. Affect. Disord. 165 (2014), 131–134.
189. Ketter, T.A., Kimbrell, T.A., George, M.S., Dunn, R.T., Speer, A.M., Benson, B.E., Willis, M.W., Danielson, A., Frye, M.A., Herscovitch, P., Post, R.M., Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol. Psychiatry 49 (2001), 97–109.
190. Khan, N.A., Auranen, M., Paetau, I., Pirinen, E., Euro, L., Forsström, S., Pasila, L., Velagapudi, V., Carroll, C.J., Auwerx, J., Suomalainen, A., Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol. Med., 2014.
191. Khan, R.S., Dine, K., Das Sarma, J., Shindler, K.S., SIRT1 Activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease. Acta Neuropathol. Commun., 2, 2014, 3.
192. Kim, H.K., Andreazza, A.C., The relationship between oxidative stress and post-translational modification of the dopamine transporter in bipolar disorder. Expert Rev. Neurother. 12 (2012), 849–859.
193. Kim, J.S., Coon, S.L., Blackshaw, S., Cepko, C.L., Moller, M., Mukda, S., Zhao, W.Q., Charlton, C.G., Klein, D.C., Methionine adenosyltransferase: adrenergic-cAMP mechanism regulates a daily rhythm in pineal expression. J. Biol. Chem. 280 (2004), 677–684.
194. Kim, D.J., Lyoo, I.K., Yoon, S.J., Choi, T., Lee, B., Kim, J.E., Lee, J.S., Renshaw, P.F., Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007), 1182–1188.
195. Kim, H.K., Andreazza, A.C., Yeung, P.Y., Isaacs-Trepanier, C., Young, L.T., Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia. J. Psychiatry Neurosci.: JPN 39 (2014), 276–285.
196. Kim, Y., McGee, S., Czeczor, J.K., Walker, A.J., Kale, R.P., Kouzani, A.Z., Walder, K., Berk, M., Tye, S.J., Nucleus accumbens deep-brain stimulation efficacy in ACTH-pretreated rats: alterations in mitochondrial function relate to antidepressant-like effects. Transl. Psychiatry, 6, 2016, e842.
197. Kirichenko, A.V., Pfitzner, U., Ludwig, B., Soares, C.M., Vygodina, T.V., Konstantinov, A.A., Cytochrome c oxidase as a calcium binding protein. Studies on the role of a conserved aspartate in helices XI-XII cytoplasmic loop in cation binding. Biochemistry 44 (2005), 12391–12401.
198. Kitzenberg, D., Colgan, S.P., Glover, L.E., Creatine kinase in ischemic and inflammatory disorders. Clin. Transl. Med., 5, 2016, 31.
199. Ko, H.J., Zhang, Z., Jung, D.Y., Jun, J.Y., Ma, Z., Jones, K.E., Chan, S.Y., Kim, J.K., Nutrient stress activates inflammation and reduces glucose metabolism by suppressing AMP-activated protein kinase in the heart. Diabetes 58 (2009), 2536–2546.
200. Kondratova, A.A., Kondratov, R.V., The circadian clock and pathology of the ageing brain. Nat. Rev. Neurosci. 13 (2012), 325–335.
201. Konradi, C., Eaton, M., MacDonald, M., Walsh, J., Benes, F., Heckers, S., Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch. Gen. Psychiatry 61 (2004), 300–308.
202. Kraguljac, N.V., Reid, M., White, D., Jones, R., den Hollander, J., Lowman, D., Lahti, A.C., Neurometabolites in schizophrenia and bipolar disorder—a systematic review and meta-analysis. Psychiatry Res. 203 (2012), 111–125.
203. Kunz, M., Gama, C., Andreazza, A., Salvador, M., Cereser, K., Gomes, F., Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2008), 1677–1681.
204. Kutzing, M.K., Firestein, B.L., Altered uric acid levels and disease states. J. Pharmacol. Exp. Ther. 324 (2008), 1–7.
205. Lamia, K.A., Sachdeva, U.M., DiTacchio, L., Williams, E.C., Alvarez, J.G., Egan, D.F., Vasquez, D.S., Juguilon, H., Panda, S., Shaw, R.J., Thompson, C.B., Evans, R.M., AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science 326 (2009), 437–440.
206. Lanaspa, M.A., Cicerchi, C., Garcia, G., Li, N., Roncal-Jimenez, C.A., Rivard, C.J., Hunter, B., Andres-Hernando, A., Ishimoto, T., Sanchez-Lozada, L.G., Thomas, J., Hodges, R.S., Mant, C.T., Johnson, R.J., Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver. PLoS One, 7, 2012, e48801.
207. Laplante, M., Sabatini, D.M., mTOR signaling at a glance. J. Cell Sci. 122 (2009), 3589–3594.
208. Lardy, H.A., Wellman, H., Oxidative phosphorylations; role of inorganic phosphate and acceptor systems in control of metabolic rates. J. Biol. Chem. 195 (1952), 215–224.
209. Lawlis, V.B., Roche, T., Effect of micromolar Ca2+ on NADH inhibition of bovine kidney?-ketoglutarate dehydrogenase complex and possible role of Ca2+ in signal amplification. Mol. Cell. Biochem., 32, 1980.
210. Lawrence, M.S., Sun, G.H., Kunis, D.M., Saydam, T.C., Dash, R., Ho, D.Y., Sapolsky, R.M., Steinberg, G.K., Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke. J. Cereb. Blood Flow Metab., 1996, 181–185.
211. Lee, B., Cao, R., Choi, Y.-S., Cho, H.-Y., Rhee, A.D., Hah, C.K., Hoyt, K.R., Obrietan, K., The CREB/CRE transcriptional pathway: protection against oxidative stress-mediated neuronal cell death. J. Neurochem. 108 (2009), 1251–1265.
212. Lee, I., Salomon, A.R., Yu, K., Samavati, L., Pecina, P., Pecinova, A., Huttemann, M., Isolation of regulatory-competent, phosphorylated cytochrome C oxidase. Methods Enzymol. 457 (2009), 193–210.
213. Leibenluft, E., Albert, P.S., Rosenthal, N.E., Wehr, T.A., Relationship between sleep and mood in patients with rapid-cycling bipolar disorder. Psychiatry Res. 63 (1996), 161–168.
214. Li, J.Z., Vawter, M.P., Walsh, D.M., Tomita, H., Evans, S.J., Choudary, P.V., Lopez, J.F., Avelar, A., Shokoohi, V., Chung, T., Mesarwi, O., Jones, E.G., Watson, S.J., Akil, H., Bunney, W.E., Myers, R.M., Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum. Mol. Genet. 13 (2004), 609–616.
215. Li, Y., Park, J.-S., Deng, J.-H., Bai, Y., Cytochrome c oxidase subunit IV is essential for assembly and respiratory function of the enzyme complex. J. Bioenerg. Biomembr. 38 (2006), 283–291.
216. Li, X., Friedman, A.B., Zhu, W., Wang, L., Boswell, S., May, R.S., Davis, L.L., Jope, R.S., Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder. Biol. Psychiatry 61 (2007), 216–222.
217. Li, X., Liu, M., Cai, Z., Wang, G., Li, X., Regulation of glycogen synthase kinase-3 during bipolar mania treatment. Bipolar Disord. 12 (2010), 741–752.
218. Li, C., Li, Y., He, L., Agarwal, A.R., Zeng, N., Cadenas, E., Stiles, B.L., PI3K/AKT signaling regulates bioenergetics in immortalized hepatocytes. Free Radic. Biol. Med. 60 (2013), 29–40.
219. Lin, Y.-S., Cheng, T.-H., Chang, C.-P., Chen, H.-M., Chern, Y., Enhancement of brain-type creatine kinase activity ameliorates neuronal deficits in Huntington's disease. Biochim. et Biophys. Acta (BBA)—Mol. Basis Dis. 1832 (2013), 742–753.
220. Lipp, P., Reither, G., Protein kinase C: the ‘masters’ of calcium and lipid. Cold Spring Harb. Perspect. Biol., 2011, 3.
221. Liu, X., Liu, M., Chen, M., Ge, Q.-M., Pan, S.-M., Serum uric acid is neuroprotective in chinese patients with acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator. J. Stroke Cerebrovasc. Dis. 24 (2015), 1080–1086.
222. Lowthert, L., Leffert, J., Lin, A., Umlauf, S., Maloney, K., Muralidharan, A., Lorberg, B., Mane, S., Zhao, H., Sinha, R., Bhagwagar, Z., Beech, R., Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation. Biol. Mood Anxiety Disord., 2, 2012, 15.
223. Ludtmann, M.H.R., Angelova, P.R., Zhang, Y., Abramov, A.Y., Dinkova-Kostova, A.T., Nrf2 affects the efficiency of mitochondrial fatty acid oxidation. Biochem. J. 457 (2014), 415–424.
224. Lundkvist, G.B., A calcium flux is required for circadian rhythm generation in mammalian pacemaker neurons. J. Neurosci. 25 (2005), 7682–7686.
225. Mühl, H., STAT3, a key parameter of cytokine-driven tissue protection during sterile inflammation—the case of experimental acetaminophen (paracetamol)-induced liver damage. Front. Immunol., 7, 2016.
226. Ma, K., Yang, L.-m., Chen, H.-z., Lu, Y., Activation of muscarinic receptors inhibits glutamate-induced GSK-3β overactivation in PC12 cells. Acta Pharmacol. Sin. 34 (2013), 886–892.
227. MacDonald, M.L., Naydenov, A., Chu, M., Matzilevich, D., Konradi, C., Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disord. 8 (2006), 255–264.
228. Machado-Vieira, R., Andreazza, A.C., Viale, C.I., Zanatto, V., Cereser, V., Vargas, R.D.S., Kapczinski, F., Portela, L.V., Souza, D.O., Salvador, M., Gentil, V., Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci. Lett. 421 (2007), 33–36.
229. Machado-Vieira, R., Pivovarova, N.B., Stanika, R.I., Yuan, P., Wang, Y., Zhou, R., Zarate, C.A., Drevets, W.C., Brantner, C.A., Baum, A., Laje, G., McMahon, F.J., Chen, G., Du, J., Manji, H.K., Andrews, S.B., The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-Mediated endoplasmic reticulum calcium release in subjects with bipolar disorder. Biol. Psychiatry 69 (2011), 344–352.
230. Maes, M., Bosmans, E., Calabrese, J., Smith, R., Meltzer, H.Y., Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J. Psychiatr. Res. 29 (1995), 141–152.
231. Magnone, M.C., Langmesser, S., Bezdek, A.C., Tallone, T., Rusconi, S., Albrecht, U., The mammalian circadian clock gene per2 modulates cell death in response to oxidative stress. Front. Neurol., 5, 2014, 289.
232. Manfredi, G., Kwong, J.Q., Oca-Cossio, J.A., Woischnik, M., Gajewski, C.D., Martushova, K., D'Aurelio, M., Friedlich, A.L., Moraes, C.T., BCL-2 improves oxidative phosphorylation and modulates adenine nucleotide translocation in mitochondria of cells harboring mutant mtDNA. J. Biol. Chem. 278 (2002), 5639–5645.
233. Manfredi, G., Kwong, J.Q., Oca-Cossio, J.A., Woischnik, M., Gajewski, C.D., Martushova, K., D'Aurelio, M., Friedlich, A.L., Moraes, C.T., BCL-2 improves oxidative phosphorylation and modulates adenine nucleotide translocation in mitochondria of cells harboring mutant mtDNA. J. Biol. Chem. 278 (2003), 5639–5645.
234. Manji, H.K., Lenox, R.H., The nature of bipolar disorder. J. Clin. Psychiatry 61:Suppl. 13 (2000), 42–57.
235. Manor, I., Hermesh, H., Valevski, A., Benjamin, Y., Munitz, H., Weizman, A., Recurrence pattern of serum creatine phosphokinase levels in repeated acute psychosis. Biol. Psychiatry 43 (1998), 288–292.
236. Mariappan, N., Elks, C., Fink, B., Francis, J., TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction. Free Radic. Biol. Med. 46 (2009), 462–470.
237. Maronde, E., Schomerus, C., Stehle, J.H., Korf, H.W., Control of CREB phosphorylation and its role for induction of melatonin synthesis in rat pinealocytes. Biol. Auspices Eur. Cell Biol. Organ. 89 (1997), 505–511.
238. Maronde, E., Wicht, H., Tasken, K., Genieser, H.G., Dehghani, F., Olcese, J., Korf, H.W., CREB phosphorylation and melatonin biosynthesis in the rat pineal gland: involvement of cyclic AMP dependent protein kinase type II. J. Pineal Res. 27 (1999), 170–182.
239. Marshall, H.E., Stamler, J.S., Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 40 (2001), 1688–1693.
240. Marshall, S.E., McCormack, J.G., Denton, R.M., Role of Ca 2+ ions in the regulation of intramitochondrial metabolism in rat epididymal adipose tissue. Evidence against a role for Ca 2+ in the activation of pyruvate dehydrogenase by insulin. Biochem. J. 218 (1984), 249–260.
241. Mattson, M.P., Gleichmann, M., Cheng, A., Mitochondria in neuroplasticity and neurological disorders. Neuron 60 (2008), 748–766.
242. McCormack, J.G., Denton, R.M., Intracellular calcium ions and intramitochondrial Ca in the regulation of energy metabolism in mammalian tissues. Proc. Nutr. Soc. 49 (1990), 57–75.
243. 2+ in the regulation of energy metabolism. Dev. Neurosci. 15 (1993), 165–173.
244. McDonald, M.L., MacMullen, C., Liu, D.J., Leal, S.M., Davis, R.L., Genetic association of cyclic AMP signaling genes with bipolar disorder. Transl. Psychiatry, 2, 2012, e169.
245. McNamara, R.K., Lotrich, F.E., Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?. Expert Rev. Neurother. 12 (2012), 1143–1161.
246. Meares, G.P., Qin, H., Liu, Y., Holdbrooks, A.T., Benveniste, E.N., 2013 AMP-activated protein kinase restricts IFN-gamma signaling. J. Immunol. (Baltimore, Md.: 1950) 190 (2013), 372–380.
247. Michael, N., Erfurth, A., Ohrmann, P., Gossling, M., Arolt, V., Heindel, W., Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology (Berl.) 168 (2003), 344–346.
248. Mildaziene, V., Baniene, R., Nauciene, Z., Bakker, B.M., Brown, G.C., Westerhoff, H.V., Kholodenko, B.N., Calcium indirectly increases the control exerted by the adenine nucleotide translocator over 2-oxoglutarate oxidation in rat heart mitochondria. Arch. Biochem. Biophys. 324 (1995), 130–134.
249. Moffett, J., Arun, P., Ariyannur, P., Namboodiri, A., N-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation. Front. Neuroenerg., 5, 2013.
250. Moon, M.H., Jeong, J.K., Lee, Y.J., Seol, J.W., Jackson, C.J., Park, S.Y., SIRT1, a class III histone deacetylase, regulates TNF-α-induced inflammation in human chondrocytes. Osteoarthr. Cartil. 21 (2013), 470–480.
251. Moore, C.M., Biederman, J., Wozniak, J., Mick, E., Aleardi, M., Wardrop, M., Dougherty, M., Harpold, T., Hammerness, P., Randall, E., Lyoo, I.K., Renshaw, P.F., Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex. J. Affect. Disord. 99 (2007), 19–25.
252. Moreschi, I., Bruzzone, S., Nicholas, R.A., Fruscione, F., Sturla, L., Benvenuto, F., Usai, C., Meis, S., Kassack, M.U., Zocchi, E., De Flora, A., Extracellular NAD+ is an agonist of the human P2Y11 purinergic receptor in human granulocytes. J. Biol. Chem. 281 (2006), 31419–31429.
253. Morgan, M., Liu, Z., Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 21 (2011), 103–115.
254. Mori, T., Miyamoto, T., Yoshida, H., Asakawa, M., Kawasumi, M., Kobayashi, T., Morioka, H., Chiba, K., Toyama, Y., Yoshimura, A., IL-1beta and TNFalpha-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis. Int. Immunol. 23 (2011), 701–712.
255. Morris, G., Berk, M., The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med., 13, 2015, 68.
256. Morris, G., Maes, M., Oxidative and nitrosative stress and immune-inflammatory pathways in patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS). Curr. Neuropharmacol. 12 (2014), 168–185.
257. Mortenson, M.M., Galante, J.G., Gilad, O., Schlieman, M.G., Virudachalam, S., Kung, H.-J., Bold, R.J., BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer. J. Cell. Biochem. 102 (2007), 1171–1179.
258. Munakata, K., Iwamoto, K., Bundo, M., Kato, T., Mitochondrial DNA 3243A > G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol. Psychiatry 57 (2005), 525–532.
259. Muneer, A., Bipolar disorder: role of inflammation and the development of disease biomarkers. Psychiatry Investig. 13 (2016), 18–33.
260. Munkholm, K., Vinberg, M., Vedel Kessing, L., Cytokines in bipolar disorder: a systematic review and meta-analysis. J. Affect. Disord. 144 (2013), 16–27.
261. Murphy, A.N., Bredesen, D.E., Cortopassi, G., Wang, E., Fiskum, G., Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc. Natl. Acad. Sci. 93 (1996), 9893–9898.
262. Murphy, S.H., Suzuki, K., Downes, M., Welch, G.L., De Jesus, P., Miraglia, L.J., Orth, A.P., Chanda, S.K., Evans, R.M., Verma, I.M., Tumor suppressor protein (p)53, is a regulator of NF- B repression by the glucocorticoid receptor. Proc. Natl. Acad. Sci. 108 (2011), 17117–17122.
263. Muti, M., Del Grande, C., Musetti, L., Marazziti, D., Turri, M., Cirronis, M., Pergentini, I., Corsi, M., Dell'Osso, L., Corsini, G.U., Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium. Psychiatry Res. 225 (2015), 604–608.
264. Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., Sassone-Corsi, P., Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324 (2009), 654–657.
265. Nakano, M., Imamura, H., Nagai, T., Noji, H., Ca2+ regulation of mitochondrial ATP synthesis visualized at the single cell level. ACS Chem. Biol. 6 (2011), 709–715.
266. Nakazato, R., Takarada, T., Yamamoto, T., Hotta, S., Hinoi, E., Yoneda, Y., Selective upregulation of per1 mRNA expression by ATP through activation of P2×7 purinergic receptors expressed in microglial cells. J. Pharmacol. Sci. 116 (2011), 350–361.
267. Nasimi, P., Tabandeh, M.R., Vahdati, A., Khatamsaz, S., Busulfan induces oxidative stress- and Bcl-2 family gene-related apoptosis in epididymal sperm and testis of adult male mice. Physiol. Pharmacol. 19 (2015), 208–215.
268. Naydenov, A.V., MacDonald, M.L., Ongur, D., Konradi, C., Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Arch Gen Psychiatry 64:5 (2007), 555–564.
269. Nierenberg, A.A., Kansky, C., Brennan, B.P., Shelton, R.C., Perlis, R., Iosifescu, D.V., Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development. Aust. N. Z. J. Psychiatry 47 (2013), 26–42.
270. Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., Burns, M., Krishnamurthy, P., Wen, Y., Bhat, R., Lewis, J., Dickson, D., Duff, K., Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc. Natl. Acad. Sci. 102 (2005), 6990–6995.
271. Nováková, M., Praško, J., Látalová, K., Sládek, M., Sumová, A., The circadian system of patients with bipolar disorder differs in episodes of mania and depression. Bipolar Disord. 17 (2014), 303–314.
272. Nowak, G., Soundararajan, S., Mestril, R., Protein kinase C-α interaction with iHSP70 in mitochondria promotes recovery of mitochondrial function after injury in renal proximal tubular cells. Am. J. Physiol.—Renal Physiol. 305 (2013), F764–F776.
273. O'Shea, P.S., Petrone, G., Casey, R.P., Azzi, A., The current-voltage relationships of liposomes and mitochondria. Biochem. J. 219 (1984), 719–726.
274. Oakes, S.A., Opferman, J.T., Pozzan, T., Korsmeyer, S.J., Scorrano, L., Regulation of endoplasmic reticulum Ca2+ dynamics by proapoptotic BCL-2 family members. Biochem. Pharmacol. 66 (2003), 1335–1340.
275. Offen, D., Ziv, I., Panet, H., Wasserman, L., Stein, R., Melamed, E., Barzilai, A., Cell. Mol. Neurobiol. 17 (1997), 289–304.
276. Ohara, K., Isoda, H., Suzuki, Y., Takehara, Y., Ochiai, M., Takeda, H., Igarashi, Y., Ohara, K., Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder. Psychiatry Res. 84 (1998), 55–60.
277. Ojuka, E.O., Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc. Nutr. Soc. 63 (2004), 275–278.
278. Ortiz, R., Ulrich, H., Zarate, C.A., Machado-Vieira, R., Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 57 (2015), 117–131.
279. Pal, S., Bhattacharjee, A., Ali, A., Mandal, N.C., Mandal, S.C., Pal, M., Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism. J. Inflamm., 11, 2014, 23.
280. Palmieri, L., Pardo, B., Lasorsa, F.M., del Arco, A., Kobayashi, K., Iijima, M., Runswick, M.J., Walker, J.E., Saheki, T., Satrústegui, J., Palmieri, F., Citrin and aralar1 are Ca2+-stimulated aspartate/glutamate transporters in mitochondria. EMBO J. 20 (2001), 5060–5069.
281. Palomer, X., Alvarez-Guardia, D., Rodriguez-Calvo, R., Coll, T., Laguna, J., Davidson, M., TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. Cardiovasc. Res. 81 (2009), 703–712.
282. Palty, R., Silverman, W.F., Hershfinkel, M., Caporale, T., Sensi, S.L., Parnis, J., Nolte, C., Fishman, D., Shoshan-Barmatz, V., Herrmann, S., Khananshvili, D., Sekler, I., NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc. Natl. Acad. Sci. 107 (2009), 436–441.
283. Pan, J.Q., Lewis, M.C., Ketterman, J.K., Clore, E.L., Riley, M., Richards, K.R., Berry-Scott, E., Liu, X., Wagner, F.F., Holson, E.B., Neve, R.L., Biechele, T.L., Moon, R.T., Scolnick, E.M., Petryshen, T.L., Haggarty, S.J., AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. Neuropsychopharmacology 36 (2011), 1397–1411.
284. Parcellier, A., Tintignac, L.A., Zhuravleva, E., Hemmings, B.A., PKB and the mitochondria: AKTing on apoptosis. Cell. Signal. 20 (2008), 21–30.
285. Pardo, B., Contreras, L., Serrano, A., Ramos, M., Kobayashi, K., Iijima, M., Saheki, T., Satrustegui, J., Essential role of Aralar in the transduction of small Ca+ signals to neuronal mitochondria. J. Biol. Chem. 281 (2005), 1039–1047.
286. Park, S.U., Ferrer, J.V., Javitch, J.A., Kuhn, D.M., Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons. J. Neurosci. 22 (2002), 4399–4405.
287. Pasalic, D., Marinkovic, N., Feher-Turkovic, L., Uric acid as one of the important factors in multifactorial disorders −facts and controversies. Biochem. Med. 22 (2012), 63–75.
288. Peek, C.B., Affinati, A.H., Ramsey, K.M., Kuo, H.-Y., Yu, W., Sena, L.A., Ilkayeva, O., Marcheva, B., Kobayashi, Y., Omura, C., Levine, D.C., Bacsik, D.J., Gius, D., Newgard, C.B., Goetzman, E., Chandel, N.S., Denu, J.M., Mrksich, M., Bass, J., Circadian clock NAD(+) cycle drives mitochondrial oxidative metabolism in mice. Science (New York, N.Y.), 342, 2013, 1243417.
289. Pfaffenseller, B., Wollenhaupt-Aguiar, B., Fries, G.R., Colpo, G.D., Burque, R.K., Bristot, G., Ferrari, P., Ceresér, K.M.M., Rosa, A.R., Klamt, F., Kapczinski, F., Impaired endoplasmic reticulum stress response in bipolar disorder: cellular evidence of illness progression. Int. J. Neuropsychopharmacol. 17 (2014), 1453–1463.
290. Piantadosi, C.A., Suliman, H.B., Redox regulation of mitochondrial biogenesis. Free Radic. Biol. Med. 53 (2012), 2043–2053.
291. Piantadosi, C.A., Regulation of mitochondrial processes by protein S-nitrosylation. Biochim. Biophys. Acta 1820 (2012), 712–721.
292. Piccinni, A., Veltri, A., Costanzo, D., Vanelli, F., Franceschini, C., Moroni, I., Domenici, L., Origlia, N., Marazziti, D., Akiskal, H.S., Dell'Osso, L., Decreased plasma levels of brain-derived neurotrophic factor (BDNF) during mixed episodes of bipolar disorder. J. Affect. Disord. 171 (2015), 167–170.
293. Plante, D.T., Winkelman, J.W., Sleep disturbance in bipolar disorder: therapeutic implications. Am. J. Psychiatry 165 (2008), 830–843.
294. Polter, A., Beurel, E., Yang, S., Garner, R., Song, L., Miller, C.A., Sweatt, J.D., McMahon, L., Bartolucci, A.A., Li, X., Jope, R.S., Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Neuropsychopharmacology, 2010.
295. Porat, S., Simantov, R., Bcl-2 and p53: role in dopamine-induced apoptosis and differentiation. Ann. N. Y. Acad. Sci. 893 (1999), 372–375.
296. Post, R.M., Leverich, G.S., The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. FOC 5 (2007), 73–97.
297. Proctor, P.H., Uric acid and neuroprotection. Stroke: J. Cereb. Circ., 39, 2008, e126.
298. Quan, X., Nguyen, T.T., Choi, S.-K., Xu, S., Das, R., Cha, S.-K., Kim, N., Han, J., Wiederkehr, A., Wollheim, C.B., Park, K.-S., Essential role of mitochondrial Ca2+ uniporter in the generation of mitochondrial pH gradient and metabolism-Secretion coupling in insulin-releasing cells. J. Biol. Chem. 290 (2014), 4086–4096.
299. Ramzan, R., Staniek, K., Kadenbach, B., Vogt, S., Mitochondrial respiration and membrane potential are regulated by the allosteric ATP-inhibition of cytochrome c oxidase. Biochim. Biophys. Acta (BBA)—Bioenergetics 1797 (2010), 1672–1680.
300. Randle, P.J., Metabolic fuel selection: general integration at the whole-body level. Proc. Nutr. Soc. 54 (1995), 317–327.
301. Rao, J.S., Kellom, M., Reese, E.A., Rapoport, S.I., Kim, H.-W., Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J. Affect. Disord. 136 (2012), 63–71.
302. Regenold, W., Phatak, P., Marano, C., Sassan, A., Conley, R., Kling, M., Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis. Biol. Psychiatry 65 (2009), 489–494.
303. Remels, A., Gosker, H., Schrauwen, P., Hommelberg, P., Sliwinski, P., Polkey, M., TNF-alpha impairs regulation of muscle oxidative phenotype: implications for cachexia?. FASEB J. 24 (2010), 5052–5062.
304. Remlinger-Molenda, A., Wojciak, P., Michalak, M., Karczewski, J., Rybakowski, J.K., Selected cytokine profiles during remission in bipolar patients. Neuropsychobiology 66 (2012), 193–198.
305. Ren, X., Rizavi, H.S., Khan, M.A., Bhaumik, R., Dwivedi, Y., Pandey, G.N., Alteration of cyclic-AMP response element binding protein in the postmortem brain of subjects with bipolar disorder and schizophrenia. J. Affect. Disord. 152–154 (2014), 326–333.
306. Roberts, D.J., Miyamoto, S., Hexokinase II integrates energy metabolism and cellular protection: akting on mitochondria and TORCing to autophagy. Cell Death Differ., 22, 2015, 364.
307. Roberts, D.J., Tan-Sah, V.P., Smith, J.M., Miyamoto, S., Akt phosphorylates HK-II at Thr-473 and increases mitochondrial HK-II association to protect cardiomyocytes. J. Biol. Chem., 288, 2013, 32638.
308. Ropelle, E.R., Fernandes, M.F.A., Flores, M.B.S., Ueno, M., Rocco, S., Marin, R., Cintra, D.E., Velloso, L.A., Franchini, K.G., Saad, M.J.A., Carvalheira, J.B.C., Central exercise action increases the AMPK and mTOR response to leptin. PLoS One, 3, 2008, e3856.
309. Rowe, M.K., Wiest, C., Chuang, D.-M., GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder. Neurosci. Biobehav. Rev. 31 (2007), 920–931.
310. Roy, A., Ganguly, A., BoseDasgupta, S., Das, B.B., Pal, C., Jaisankar, P., Majumder, H.K., Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3,3'-diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani. Mol. Pharmacol. 74 (2008), 1292–1307.
311. Ruderman, N.B., Keller, C., Richard, A.M., Saha, A.K., Luo, Z., Xiang, X., Giralt, M., Ritov, V.B., Menshikova, E.V., Kelley, D.E., Hidalgo, J., Pedersen, B.K., Kelly, M., Interleukin-6 regulation of AMP-activated protein kinase: potential role in the systemic response to exercise and prevention of the metabolic syndrome. Diabetes 55 (2006), S48–S54.
312. Rutter, G.A., Pralong, W.-F., Wollheim, C.B., Regulation of mitochondrial glycerol-phosphate dehydrogenase by Ca2+ within electropermeabilized insulin-secreting cells (INS-1). Biochim. Biophys. Acta (BBA)—Mol. Cell Res. 1175 (1992), 107–113.
313. Rybakowski, J.K., Dmitrzak-Weglarz, M., Kliwicki, S., Hauser, J., Polymorphism of circadian clock genes and prophylactic lithium response. Bipolar Disord. 16 (2013), 151–158.
314. Salminen, A., Kaarniranta, K., Glycolysis links p53 function with NF-kappaB signaling: impact on cancer and aging process. J. Cell. Physiol. 224 (2010), 1–6.
315. Salminen, A., Kaarniranta, K., Kauppinen, A., Crosstalk between oxidative stress and SIRT1: impact on the aging process. IJMS 14 (2013), 3834–3859.
316. Salvadore, G., Viale, C.I., Luckenbaugh, D.A., Zanatto, V.C., Portela, L.V., Souza, D.O., Zarate, C.A., Machado-Vieira, R., Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episode. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 34 (2010), 819–821.
317. Salvatore, P., Ghidini, S., Zita, G., Panfilis, C.D., Lambertino, S., Maggini, C., Baldessarini, R.J., Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients. Bipolar Disord. 10 (2008), 256–265.
318. Sassone-Corsi, P., Minireview: NAD+, a circadian metabolite with an epigenetic twist. Endocrinology 153 (2012), 1–5.
319. Satrustegui, J., Pardo, B., del Arco, A., Mitochondrial transporters as novel targets for intracellular calcium signaling. Physiol. Rev. 87 (2007), 29–67.
320. Scarpulla, R.C., Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim. Biophys. Acta (BBA)—Mol. Cell Res. 1813 (2011), 1269–1278.
321. Scherk, H., Backens, M., Schneider-Axmann, T., Kemmer, C., Usher, J., Reith, W., Falkai, P., Gruber, O., Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder. Acta Psychiatr. Scand. 117 (2008), 283–288.
322. Schlattner, U., Tokarska-Schlattner, M., Wallimann, T., Mitochondrial creatine kinase in human health and disease. Biochim. Biophys. Acta (BBA)—Mol. Basis Dis. 1762 (2006), 164–180.
323. Schubert, K.O., Föcking, M., Cotter, D.R., Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: potential roles in GABAergic interneuron pathology. Schizophr. Res. 167 (2015), 64–72.
324. Segal, M., Avital, A., Drobot, M., Lukanin, A., Derevenski, A., Sandbank, S., Weizman, A., CK levels in unmedicated bipolar patients. Eur. Neuropsychopharmacol. 17 (2007), 763–767.
325. Segal, M., Avital, A., Drobot, M., Lukanin, A., Derevenski, A., Sandbank, S., Weizman, A., Serum creatine kinase level in unmedicated nonpsychotic, psychotic, bipolar and schizoaffective depressed patients. Eur. Neuropsychopharmacol. 17 (2007), 194–198.
326. Segerstrom, S.C., Miller, G.E., Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 130 (2004), 601–630.
327. Shaw, R.J., Cantley, L.C., Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441 (2006), 424–430.
328. Sheppard, C.L., Lee, L.C.Y., Hill, E.V., Henderson, D.J.P., Anthony, D.F., Houslay, D.M., Yalla, K.C., Cairns, L.S., Dunlop, A.J., Baillie, G.S., Huston, E., Houslay, M.D., Mitotic activation of the DISC1-inducible cyclic AMP phosphodiesterase-4D9 (PDE4D9), through multi-site phosphorylation, influences cell cycle progression. Cell. Signal. 26 (2014), 1958–1974.
329. Shinozaki, S., Chang, K., Sakai, M., Shimizu, N., Yamada, M., Tanaka, T., Nakazawa, H., Ichinose, F., Yamada, Y., Ishigami, A., Ito, H., Ouchi, Y., Starr, M.E., Saito, H., Shimokado, K., Stamler, J.S., Kaneki, M., Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65. Sci. Signal., 7, 2014, ra106.
330. Sid, B., Verrax, J., Calderon, P.B., Role of AMPK activation in oxidative cell damage: implications for alcohol-induced liver disease. Biochem. Pharmacol. 86 (2013), 200–209.
331. Signoretti, S., Di Pietro, V., Vagnozzi, R., Lazzarino, G., Amorini, A., Belli, A., D'Urso, S., Tavazzi, B., Transient alterations of creatine, creatine phosphate, N-acetylaspartate and high-energy phosphates after mild traumatic brain injury in the rat. Mol. Cell. Biochem. 333 (2010), 269–277.
332. So, J., Warsh, J.J., Li, P.P., Impaired endoplasmic reticulum stress response in B-lymphoblasts from patients with bipolar-I disorder. Biol. Psychiatry 62 (2007), 141–147.
333. Soeiro-de-Souza, M.G., Salvadore, G., Moreno, R.A., Otaduy, M.C.G., Chaim, K.T., Gattaz, W.F., Zarate, C.A., Machado-Vieira, R., Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder. Neuropsychopharmacology 38 (2012), 468–475.
334. Sperlágh, B., Hracskó, Z., Baranyi, M., Csölle, C., Gölöncsér, F., Kittel, Á., Madarász, E., The double-faced role of P2×7 receptors in toxin-induced animal models of Parkinson's disease. BMC Pharmacol., 11, 2011, A56.
335. Spiliotaki, M., Salpeas, V., Malitas, P., Alevizos, V., Moutsatsou, P., Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients. Psychoneuroendocrinology 31 (2006), 748–760.
336. Srinivasan, V., Spence, D.W., Pandi-Perumal, S.R., Brown, G.M., Cardinali, D.P., Melatonin in mitochondrial dysfunction and related disorders. Int. J. Alzheimer Dis. 2011 (2011), 1–16.
337. Srinivasan, S., Spear, J., Chandran, K., Joseph, J., Kalyanaraman, B., Avadhani, N.G., Oxidative stress induced mitochondrial protein kinase A mediates cytochrome c oxidase dysfunction. PLoS One, 8, 2013, e77129.
338. Stangherlin, A., Reddy, A.B., Regulation of circadian clocks by redox homeostasis. J. Biol. Chem. 288 (2013), 26505–26511.
339. Stein, L.R., Imai, S., The dynamic regulation of NAD metabolism in mitochondria. ABBV Trends Endocrinol. Metab. 23 (2012), 420–428.
340. Steinberg, G.R., Michell, B.J., van Denderen, B.J., Watt, M.J., Carey, A.L., Fam, B.C., Andrikopoulos, S., Proietto, J., Gorgun, C.Z., Carling, D., Hotamisligil, G.S., Febbraio, M.A., Kay, T.W., Kemp, B.E., Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab. 4 (2006), 465–474.
341. Steinberg, G.R., Watt, M.J., Febbraio, M.A., Cytokine regulation of AMPK signalling. Front. Biosci. (Landmark edition) 14 (2009), 1902–1916.
342. Steinberg, S.F., Mechanisms for redox-regulation of protein kinase C. Front. Pharmacol., 6, 2015, 128.
343. Stertz, L., Fries, G.R., Rosa, A.R., Kauer-Sant'anna, M., Ferrari, P., Paz, A.V., Green, C., Cunha, A.B., Dal-Pizzol, F., Gottfried, C., Kapczinski, F., Damage-associated molecular patterns and immune activation in bipolar disorder. Acta Psychiatr. Scand. 132 (2015), 211–217.
344. Stiles, B.L., PI-3-K and AKT: onto the mitochondria. Adv. Drug Deliv. Rev. 61 (2009), 1276–1282.
345. Stork, C., Renshaw, P., Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 10 (2005), 900–919.
346. Sun, W., Barron, P.M., pH sensitive photophysical and photochemical properties of a pentaazadentate porphyrin-like gadolinium (III) complex. Front. Biosci. 1:11 (2006), 2795–2801.
347. Suzuki, S., Tanaka, T., Poyurovsky, M.V., Nagano, H., Mayama, T., Ohkubo, S., Lokshin, M., Hosokawa, H., Nakayama, T., Suzuki, Y., Sugano, S., Sato, E., Nagao, T., Yokote, K., Tatsuno, I., Prives, C., Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc. Natl. Acad. Sci. 107 (2010), 7461–7466.
348. Tahara, Y., Yokota, A., Shiraishi, T., Yamada, S., Haraguchi, A., Shinozaki, A., Shibata, S., In vitro and in vivo phase changes of the mouse circadian clock by oxidative stress. J. Circad. Rhythms, 14, 2016, 4.
349. Tamaki, N., Cristina Orihuela-Campos, R., Inagaki, Y., Fukui, M., Nagata, T., Ito, H.-O., Resveratrol improves oxidative stress and prevents the progression of periodontitis via the activation of the Sirt1/AMPK and the Nrf2/antioxidant defense pathways in a rat periodontitis model. Free Radic. Biol. Med. 75 (2014), 222–229.
350. Tamaru, T., Ikeda, M., Circadian adaptation to cell injury stresses: a crucial interplay of BMAL1 and HSF1. J. Physiol. Sci.: JPS 66 (2016), 303–306.
351. Tamaru, T., Hattori, M., Ninomiya, Y., Kawamura, G., Vares, G., Honda, K., Mishra, D.P., Wang, B., Benjamin, I., Sassone-Corsi, P., Ozawa, T., Takamatsu, K., ROS stress resets circadian clocks to coordinate pro-survival signals. PLoS One, 8, 2013, e82006.
352. Tang, K., Wagner, P.D., Breen, E.C., TNF-α−mediated reduction in PGC-1α may impair skeletal muscle function after cigarette smoke exposure. J. Cell. Physiol. 222 (2010), 320–327.
353. Tao, R., Gong, J., Luo, X., Zang, M., Guo, W., Wen, R., Luo, Z., AMPK exerts dual regulatory effects on the PI3K pathway. J. Mol. Signal., 5, 2010, 1.
354. Tarasov, A.I., Griffiths, E.J., Rutter, G.A., Regulation of ATP production by mitochondrial Ca2+. Cell Calcium 52 (2012), 28–35.
355. Tarasov, A.I., Semplici, F., Li, D., Rizzuto, R., Ravier, M.A., Gilon, P., Rutter, G.A., Frequency-dependent mitochondrial Ca2+ accumulation regulates ATP synthesis in pancreatic β cells. Pflüg. Archiv.—Eur. J. Physiol. 465 (2012), 543–554.
356. Tardito, D., Mori, S., Racagni, G., Smeraldi, E., Zanardi, R., Perez, J., Protein kinase A activity in platelets from patients with bipolar disorder. J. Affect. Disord. 76 (2003), 249–253.
357. Taylor, J.R., Abichandani, L., Creatine phosphokinase elevations and psychiatric symptomatology. Biol. Psychiatry 15 (1980), 865–870.
358. Tian, R., Hou, G., Li, D., Yuan, T.-F., A possible change process of inflammatory cytokines in the prolonged chronic stress and its ultimate implications for health. Sci. World J. 2014 (2014), 1–8.
359. Tomita, H., Ziegler, M.E., Kim, H.B., Evans, S.J., Choudary, P.V., Li, J.Z., Meng, F., Dai, M., Myers, R.M., Neal, C.R., Speed, T.P., Barchas, J.D., Schatzberg, A.F., Watson, S.J., Akil, H., Jones, E.G., Bunney, W.E., Vawter, M.P., G protein-linked signaling pathways in bipolar and major depressive disorders. Front. Genet., 4, 2013, 297.
360. Traba, J., del Arco, A., Duchen, M.R., Szabadkai, G., Satrústegui, J., SCaMC-1 promotes cancer cell survival by desensitizing mitochondrial permeability transition via ATP/ADP-mediated matrix Ca2+ buffering. Cell Death Differ. 19 (2011), 650–660.
361. Trachootham, D., Lu, W., Ogasawara, M.A., Valle, N.R.-D., Huang, P., Redox regulation of cell survival. Antioxidants Redox Signal. 10 (2008), 1343–1374.
362. Tsai, M.-C., Huang, T.-L., Thiobarbituric acid reactive substances (TBARS) is a state biomarker of oxidative stress in bipolar patients in a manic phase. J. Affect. Disord. 173 (2015), 22–26.
363. Turkan, A., Hiromasa, Y., Roche, T.E., Formation of a complex of the catalytic subunit of pyruvate dehydrogenase phosphatase isoform 1 (PDP1c) and the L2 domain forms a Ca2+ binding site and captures PDP1c as a monomer. Biochemistry 43 (2004), 15073–15085.
364. Uemura, T., Green, M., Corson, T.W., Perova, T., Li, P.P., Warsh, J.J., Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder. Bipolar Disord. 13 (2011), 41–51.
365. Uemura, T., Green, M., Warsh, J.J., CACNA1C SNP rs1006737 associates with bipolar I disorder independent of the Bcl-2 SNP rs956572 variant and its associated effect on intracellular calcium homeostasis. World J. Biol. Psychiatry, 2015, 1–10.
366. Um, J.-H., Pendergast, J.S., Springer, D.A., Foretz, M., Viollet, B., Brown, A., Kim, M.K., Yamazaki, S., Chung, J.H., AMPK regulates circadian rhythms in a tissue- and isoform-specific manner. PLoS One, 6, 2011, e18450.
367. Underwood, B.R., Understanding the neuroprotective mechanisms of lithium may have clinical significance. Br. J. Psychiatry, 199, 2011, 166.
368. Vítek, L., Novotný, L., Žák, A., Staňková, B., Zima, T., Polito, A., Cesare, G., Zerbinati, C., Iuliano, L., Relationship between serum bilirubin and uric acid to oxidative stress markers in Italian and Czech populations. J. Appl. Biomed. 11 (2013), 209–221.
369. Vaarmann, A., Kovac, S., Holmström, K.M., Gandhi, S., Abramov, A.Y., Dopamine protects neurons against glutamate-induced excitotoxicity. Cell Death Dis., 4, 2013, e455.
370. Vale, S., Creatine phosphokinase. Arch. Neurol., 30, 1974, 103.
371. Valerio, A., Cardile, A., Cozzi, V., Bracale, R., Tedesco, L., Pisconti, A., Palomba, L., Cantoni, O., Clementi, E., Moncada, S., Carruba, M.O., Nisoli, E., TNF- downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J. Clin. Invest. 116 (2006), 2791–2798.
372. Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T.D., Mazur, M., Telser, J., Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39 (2007), 44–84.
373. Valsecchi, F., Ramos-Espiritu, L.S., Buck, J., Levin, L.R., Manfredi, G., cAMP and mitochondria. Physiology (Bethesda, Md.) 28 (2013), 199–209.
374. Valsecchi, F., Konrad, C., Manfredi, G., Role of soluble adenylyl cyclase in mitochondria. Biochim. Biophys. Acta 1842 (2014), 2555–2560.
375. Vawter, M.P., Tomita, H., Meng, F., Bolstad, B., Li, J., Evans, S., Choudary, P., Atz, M., Shao, L., Neal, C., Walsh, D.M., Burmeister, M., Speed, T., Myers, R., Jones, E.G., Watson, S.J., Akil, H., Bunney, W.E., Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol. Psychiatry 11:615 (2006), 663–679.
376. Villafuerte, G., Miguel-Puga, A., Murillo Rodríguez, E., Machado, S., Manjarrez, E., Arias-Carrión, O., Sleep deprivation and oxidative stress in animal models: a systematic review. Oxid. Med. Cell. Longevity 2015 (2015), 1–15.
377. Virdee, K., Parone, P.A., Tolkovsky, A.M., Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival. Curr. Biol.: CB 10 (2000), 1151–1154.
378. Vogler, M., Hamali, H.A., Sun, X.M., Bampton, E.T.W., Dinsdale, D., Snowden, R.T., Dyer, M.J.S., Goodall, A.H., Cohen, G.M., BCL2/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood 117 (2011), 7145–7154.
379. Wang, H., Brown, J., Martin, M., Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine 53 (2011), 130–140.
380. Wang, Y.Q., Cao, Q., Wang, F., Huang, L.Y., Sang, T.T., Liu, F., Chen, S.Y., SIRT1 protects against oxidative stress-induced endothelial progenitor cells apoptosis by inhibiting FOXO3a via FOXO3a ubiquitination and degradation. J. Cell. Physiol. 230 (2015), 2098–2107.
381. Washizuka, S., Kakiuchi, C., Mori, K., Tajima, O., Akiyama, T., Kato, T., Expression of mitochondria-related genes in lymphoblastoid cells from patients with bipolar disorder. Bipolar Disord. 7 (2005), 146–152.
382. Washizuka, S., Iwamoto, K., Kakiuchi, C., Bundo, M., Kato, T., Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. Neurosci. Res. 63 (2009), 199–204.
383. Weber, W.A., Dudley, J., Lee, J.H., Strakowski, S.M., Adler, C.M., DelBello, M.P., A pilot study of alterations in high energy phosphoryl compounds and intracellular pH in unmedicated adolescents with bipolar disorder. J. Affect. Disord. 150 (2013), 1109–1113.
384. Weiser, M., Burshtein, S., Gershon, A.A., Marian, G., Vlad, N., Grecu, I.G., Tocari, E., Tiugan, A., Hotineanu, M., Davis, J.M., Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder. Bipolar Disord. 16 (2014), 441–447.
385. Whiteman, M., Ketsawatsakul, U., Halliwell, B., A reassessment of the peroxynitrite scavenging activity of uric acid. Ann. N. Y. Acad. Sci. 962 (2002), 242–259.
386. Wilson, W. 3rd, Baldwin, A.S., Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer. Cancer Res. 68 (2008), 8156–8163.
387. Wolf, A., Agnihotri, S., Micallef, J., Mukherjee, J., Sabha, N., Cairns, R., Hawkins, C., Guha, A., Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J. Cell Biol., 192, 2011, i1.
388. Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R.C., Spiegelman, B.M., Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98 (1999), 115–124.
389. Wu, A., Ying, Z., Gomez-Pinilla, F., The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur. J. Neurosci. 19 (2004), 1699–1707.
390. Wu, J.C., Kelsoe, J.R., Schachat, C., Bunney, B.G., DeModena, A., Golshan, S., Gillin, J.C., Potkin, S.G., Bunney, W.E., Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol. Psychiatry 66 (2009), 298–301.
391. Wu, S.-B., Wu, Y.-T., Wu, T.-P., Wei, Y.-H., Role of AMPK-mediated adaptive responses in human cells with mitochondrial dysfunction to oxidative stress. Biochim. Biophys. Acta (BBA)—Gen. Subjects 1840 (2014), 1331–1344.
392. Xie, J., Zhang, X., Zhang, L., Negative regulation of inflammation by SIRT1. Pharmacol. Res. 67 (2013), 60–67.
393. Xu, J., Dydak, U., Harezlak, J., Nixon, J., Dzemidzic, M., Gunn, A.D., Karne, H.S., Anand, A., Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation. Psychiatry Res.: Neuroimag. 213 (2013), 235–241.
394. Yang, H., Zhang, W., Pan, H., Feldser, H.G., Lainez, E., Miller, C., Leung, S., Zhong, Z., Zhao, H., Sweitzer, S., Considine, T., Riera, T., Suri, V., White, B., Ellis, J.L., Vlasuk, G.P., Loh, C., SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-kappaB activity. PLoS One, 7, 2012, e46364.
395. Yang, P., Gao, Z., Zhang, H., Fang, Z., Wu, C., Xu, H., Huang, Q.-J., Changes in proinflammatory cytokines and white matter in chronically stressed rats. Neuropsychiatr. Dis. Treat. 11 (2015), 597–607.
396. Ye, J., Regulation of PPARγ function by TNF-α. Biochem. Biophys. Res. Commun. 374 (2008), 405–408.
397. Yildiz-Yesiloglu, A., Ankerst, D.P., Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006), 969–995.
398. Zarate, C.A., Manji, H.K., Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder. CNS Drugs 23 (2009), 569–582.
399. Zhang, Y., Yang, J.-H., Activation of the PI3K/Akt pathway by oxidative stress mediates high glucose-induced increase of adipogenic differentiation in primary rat osteoblasts. J. Cell. Biochem. 114 (2013), 2595–2602.
400. Zhang, M., Jin, W., Zhou, X., Yu, J., Lee, A.J., Sun, S.-C., Deregulation of Tpl2 and NF-κB signaling and induction of macrophage apoptosis by the anti-depressant drug lithium. Cell Signal. 21 (2009), 559–566.
401. Zhang, S., Fritz, N., Ibarra, C., Uhlen, P., Inositol 1,4,5-trisphosphate receptor subtype-specific regulation of calcium oscillations. Neurochem. Res. 36 (2011), 1175–1185.
402. Zhang, Y., Yamamoto, T., Hisatome, I., Li, Y., Cheng, W., Sun, N., Cai, B., Huang, T., Zhu, Y., Li, Z., Jing, X., Zhou, R., Cheng, J., Uric acid induces oxidative stress and growth inhibition by activating adenosine monophosphate-activated protein kinase and extracellular signal-regulated kinase signal pathways in pancreatic β cells. Mol. Cell. Endocrinol. 375 (2013), 89–96.
403. Zhang, J., Zhu, Y., Zhan, G., Fenik, P., Panossian, L., Wang, M.M., Reid, S., Lai, D., Davis, J.G., Baur, J.A., Veasey, S., Extended wakefulness: compromised metabolics in and degeneration of locus ceruleus neurons. J. Neurosci. 34 (2014), 4418–4431.
404. Zhang, X.Y., Chen, D.C., Tan, Y.L., Tan, S.P., Wang, Z.R., Yang, F.D., Okusaga, O.O., Zunta-Soares, G.B., Soares, J.C., The interplay between BDNF and oxidative stress in chronic schizophrenia. Psychoneuroendocrinology 51 (2015), 201–208.
405. Zhong, L.T., Sarafian, T., Kane, D.J., Charles, A.C., Mah, S.P., Edwards, R.H., Bredesen, D.E., bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 4533–4537.
406. de Sousa, R.T., Machado-Vieira, R., Zarate, C.A. Jr., Manji, H.K., Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder. Expert Opin. Ther. Targets 18 (2014), 1131–1147.
407. de Sousa, R.T., Zarate, C.A., Zanetti, M.V., Costa, A.C., Talib, L.L., Gattaz, W.F., Machado-Vieira, R., Oxidative stress in early stage Bipolar Disorder and the association with response to lithium. J. Psychiatr. Res. 50 (2014), 36–41.
408. de Sousa, R.T., Zanetti, M.V., Talib, L.L., Serpa, M.H., Chaim, T.M., Carvalho, A.F., Brunoni, A.R., Busatto, G.F., Gattaz, W.F., Machado-Vieira, R., Lithium increases platelet serine-9 phosphorylated GSK-3beta levels in drug-free bipolar disorder during depressive episodes. J. Psychiatr. Res. 62 (2015), 78–83.
409. del Arco, A., Satrustegui, J., Molecular cloning of aralar, a new member of the mitochondrial carrier superfamily that binds calcium and is present in human muscle and brain. J. Biol. Chem. 273 (1998), 23327–23334.
410. del Arco, A., Satrustegui, J., Identification of a novel human subfamily of mitochondrial carriers with calcium-binding domains. J. Biol. Chem. 279 (2004), 24701–24713.